Hemophilia laboratory findings

Hemophilia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemophilia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemophilia laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemophilia laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemophilia laboratory findings
CDC on Hemophilia laboratory findings
Hemophilia laboratory findings in the news
Blogs on Hemophilia laboratory findings
Directions to Hospitals Treating Hemophilia
Risk calculators and risk factors for Hemophilia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Laboratory findings consistent with the diagnosis of hemophilia include unaffected prothrombin time, prolonged partial thromboplastin time, unaffected bleeding time and unaffected platelet count.

Screening Tests

Screening tests are blood tests that show if the blood is clotting properly. Types of screening tests:

Complete Blood Count (CBC)

This common test measures the amount of hemoglobin (the red pigment inside red blood cells that carries oxygen), the size and number of red blood cells and numbers of different types of white blood cells and platelets found in blood. The CBC is normal in people with hemophilia. However, if a person with hemophilia has unusually heavy bleeding or bleeds for a long time, the hemoglobin and the red blood cell count can be low.

Activated Partial Thromboplastin Time (APTT) Test

This test measures how long it takes for blood to clot. It measures the clotting ability of factors VIII (8), IX (9), XI (11), and XII (12). If any of these clotting factors are too low, it takes longer than normal for the blood to clot. The results of this test will show a longer clotting time among people with hemophilia A or B.

Prothrombin Time (PT) Test

This test also measures the time it takes for blood to clot. It measures primarily the clotting ability of factors I (1), II (2), V (5), VII (7), and X (10). If any of these factors are too low, it takes longer than normal for the blood to clot. The results of this test will be normal among most people with hemophilia A and B.

Fibrinogen Test

This test also helps doctors assess a patient’s ability to form a blood clot. This test is ordered either along with other blood clotting tests or when a patient has an abnormal PT or APTT test result, or both. Fibrinogen is another name for clotting factor I (1).

Clotting Factor Tests

Clotting factor tests, also called factor assays, are required to diagnose a bleeding disorder. This blood test shows the type of hemophilia and the severity. It is important to know the type and severity in order to create the best treatment plan.

Condition	Prothrombin time	Partial Thromboplastin Time	Bleeding Time	Platelet Count
Hemophilia A or B	Unaffected	Prolonged	Unaffected	Unaffected
Von Willebrand Disease	Unaffected	Prolonged or Unaffected	Prolonged	Unaffected
Thrombocytopenia	Unaffected	Unaffected	Prolonged	Decreased
Vitamin K deficiency or Warfarin	Prolonged	Normal or mildly prolonged	Unaffected	Unaffected
Disseminated Intravascular Coagulation	Prolonged	Prolonged	Prolonged	Decreased
Liver failure, early	Prolonged	Unaffected	Unaffected	Unaffected
Aspirin	Unaffected	Unaffected	Prolonged	Unaffected
Liver failure, end-stage	Prolonged	Pronlonged	Prolonged	Decreased
Uremia	Unaffected	Unaffected	Prolonged	Unaffected
Congenital afibrinogenemia	Prolonged	Prolonged	Prolonged	Unaffected
Factor V deficiency	Prolonged	Prolonged	Unaffected	Unaffected
Factor X deficiency as seen in amyloid purpura	Prolonged	Prolonged	Unaffected	Unaffected
Glanzmann's thrombasthenia	Unaffected	Unaffected	Prolonged	Unaffected
Bernard-Soulier syndrome	Unaffected	Unaffected	Prolonged	Decreased
Factor XII deficiency	Unaffected	Unaffected	Prolonged	Decreased or unaffected
C1INH deficiency	Unaffected	Shortened	Unaffected	Unaffected
Adapted from Wikipedia hemophilia Laboratory Finding> "Wikipedia Hemophilia Laboratory Finding".